Abstracts

IN SILICO PREDICTION OF MONTHLY BICTEGRAVIR MICRONEEDLE ARRAY PATCHES

Microneedle array patches (MAPs) comprise of multiple micron-scale needles that can provide painless administration of long-acting nanoformulated drug, producing effective drug plasma concentrations over extended periods of time. The current study used physiologically-based pharmacokinetic (PBPK) modelling to predict optimal dosing strategies of bictegravir (BIC) via MAP administration. A whole-body PBPK model was designed in Simbiology…

DORAVIRINE CONCENTRATIONS AND HIV-1 RNA SUPPRESSION IN MALE AND FEMALE GENITAL FLUIDS

Residual HIV replication in reservoirs might contribute to immune activation and inflammation and constitutes a barrier to eradication. Antiretroviral distribution in male and female genital tract is required to suppress HIV replication within these compartments. We determined doravirine concentrations and HIV-1 RNA in blood plasma (BP), seminal plasma (SP) and cervicovaginal fluid (CVF) of HIV-1-infected…

PREDICTED SUCCESS OF PrEP USERS’ PREFERRED NONDAILY TENOFOVIR/EMTRICITABINE REGIMENS

Adherence is critical for effective HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), yet remains a clinical challenge. TDF/FTC PrEP users are interested in less-than-daily and event-driven dosing [PMCID: PMC7228850]. Using a published model of TDF/FTC pharmacokinetics/pharmacodynamics (PK/PD) in rectal (RT), cervical (CT), and vaginal (VT) tissue [PMCID: PMC4907409], we predicted the efficacy of…